Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Bioorganic & Medicinal Chemistry|November 3, 2012
Synthesis and biological evaluation of 2-substituted-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of Medicinal Chemistry|July 16, 2014
Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazolesRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of the American Chemical Society|April 17, 2010
Structural and conformational requisites in DNA quadruplex groove binding: another piece to the puzzleSandro Cosconati, Luciana Marinelli, Roberta Trotta, et al.
Journal of Medicinal Chemistry|June 29, 2012
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonistsPier Giovanni Baraldi, Giulia Saponaro, Allan R Moorman, et al.
Molecular Pharmacology|March 25, 2005
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20Stefania Gessi, Katia Varani, Stefania Merighi, et al.
Journal of Medicinal Chemistry|March 5, 2004
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Biochemical Pharmacology|October 13, 2005
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptorsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
European Journal of Medicinal Chemistry|August 6, 2013
Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|March 18, 2015
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptorDelia Preti, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Bioorganic & Medicinal Chemistry|November 3, 2012
Synthesis and biological evaluation of 2-substituted-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of Medicinal Chemistry|July 16, 2014
Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazolesRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of the American Chemical Society|April 17, 2010
Structural and conformational requisites in DNA quadruplex groove binding: another piece to the puzzleSandro Cosconati, Luciana Marinelli, Roberta Trotta, et al.
Journal of Medicinal Chemistry|June 29, 2012
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonistsPier Giovanni Baraldi, Giulia Saponaro, Allan R Moorman, et al.
Molecular Pharmacology|March 25, 2005
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20Stefania Gessi, Katia Varani, Stefania Merighi, et al.
Journal of Medicinal Chemistry|March 5, 2004
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Biochemical Pharmacology|October 13, 2005
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptorsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
European Journal of Medicinal Chemistry|August 6, 2013
Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|March 18, 2015
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptorDelia Preti, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Pageof 16